PAPILOCARE HCP BOOKLET 2025

REPAIR OF CERVICAL LESIONS ◊ + VIRAL CLEARANCE AT 6 MONTHS WITH INTENSIVE REGIMEN 1

CLINICAL TRIAL

2

NCT 04199078

HR-HPV+ patients with low-grade lesions

HR-HPV+ patients 16,18 and 31 with low-grade lesions

**

100 90 80 70 60 50 40 30 20 10 0

100 90 80 70 60 50 40 30 20 10 0

**

93.9%

84.6%

46.4%

30.8%

Control

Papilocare®

Control

Papilocare®

n=109 p=0.0033

n=56 p= 0.0011

Papilocare® Intensive Regimen: 3 months 1 cannula per day + 3 months 1 cannula every other day

Control

◊ Low grade cervical lesions ASCUS/LSIL

1. Centeno C, Coll M, Fiol G, López B, Riera M, Valenzuela O, Sanmartín P. Ecacy of a multi-ingredient Coriolus versicolor-based vaginal gel on High-risk HPV clearance: preliminary results from the PALOMA 2 clinical trial. [Oral Communication].10th Congress of the European Federation for Colposcopy Riga, September 18-21, 2024.

Made with FlippingBook - Online magazine maker